A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer

BACKGROUND: Natural killer (NK) cells derived from patients with cancer exhibit diminished cytotoxicity compared with NK cells from healthy individuals. We evaluated the tumor response and in vivo expansion of allogeneic NK cells in recurrent ovarian and breast cancer. METHODS: Patients underwent a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Geller, Melissa A., Cooley, Sarah, Judson, Patricia L., Ghebre, Rahel, Carson, Linda F., Argenta, Peter A., Jonson, Amy L., Panoskaltsis-Mortari, Angela, Curtsinger, Julie, McKenna, David, Dusenbery, Kathryn, Bliss, Robin, Downs, Levi S., Miller, Jeffrey S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2010
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3760671/
https://ncbi.nlm.nih.gov/pubmed/20849361
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3109/14653249.2010.515582
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados